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Abstract
Objectives—To conduct outcome and process evaluations of school-located HPV vaccination 
clinics in partnership with a local health department.
Methods—Temporary clinics provided the HPV vaccine to middle school girls in Guilford 
County, North Carolina, in 2009–2010.
Results—HPV vaccine initiation was higher among girls attending host schools than satellite 
schools (6% vs. 1%, OR = 6.56, CI = 3.99–10.78). Of the girls who initiated HPV vaccine, 80% 
received all 3 doses. Private insurance or federal programs paid for most vaccine doses.
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Conclusions—Lessons learned for creating more effective school-health department 
partnerships include focusing on host schools and delivering several vaccines to adolescents, not 
just HPV vaccine alone.
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Human papillomavirus (HPV) vaccine prevents infection with HPV types that account for 
about 70% of cervical cancers in the US.1 National guidelines recommend HPV vaccine for 
routine use among 11-to-12-year-old adolescents, with catch-up vaccination for females up 
to age 26.2 However, only 35% of girls 13 to 17 years of age have received the full 3-dose 
series of HPV vaccine. 3 The low rate of coverage is surprising given that most adolescents 
in the US can receive free or low-cost HPV vaccine through private insurance or the 
federally-funded Vaccines for Children program that covers uninsured and Medicaid-
eligible children.4
A promising approach for increasing adolescent vaccine uptake, particularly for HPV 
vaccine, is voluntary provision in schools. In some areas in the United Kingdom and 
Australia, HPV vaccine completion among 11-to-12-year-old girls exceeds 80%, largely due 
to voluntary school-located programs that provide HPV vaccine.5–9 In the US, voluntary, 
school-located programs, which often involve a partnership between a local school system 
and health department, have successfully increased uptake for several vaccines;10–12 
however, few evaluations of school-located interventions to increase HPV vaccine provision 
exist,13 despite the finding from a national survey that 67% of mothers with daughters 11 to 
14 years of age were supportive of school-located HPV vaccination.14
This project sought to create a partnership between schools and a health department to 
provide HPV vaccine in extramural school-located programs. To this end, the project 
focused on the local school system and health department in Guilford County, North 
Carolina. The 2000–2009 age-adjusted cervical cancer mortality rate in Guilford County is 
higher than the rate in the 4 adjacent counties of Alamance, Rockingham, Randolph, and 
Forsyth (6.1 vs. 3.5, 3.7, 4.1, and 5.3 cases per 100,000 women annually) and is the third 
highest in the state,15,16 which highlights the benefits of HPV vaccination for girls and 
women living in this area. Prior to the launch of the intervention, the Guilford County 
Health Department conducted a countywide education campaign called “Don’t Wait… 
Educate!” that reduced misconceptions about HPV and HPV vaccine among parents, 
healthcare providers, and middle school staff and increased school staffs’ support of school-
located vaccination programs.17 Almost all parents surveyed (97%) supported offering HPV 
vaccination clinics at schools.17
Bolstered by these findings, the department launched an extramural school-located HPV 
vaccination campaign called “Don’t Wait… Vaccinate!” The present study sought to 
provide outcome and process evaluations of this intervention. The intervention goals for 
outcome measures were to administer HPV vaccine to at least 30% of middle school girls at 
a school-located clinic and have at least 90% of girls who initiate the vaccine complete the 
3-dose series. Because this intervention began before the Centers for Disease Control and 
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Prevention (CDC) recommended routine administration of HPV vaccine to boys,18 we 
targeted only girls. We hope that our report will assist others in developing and expanding 
school-located vaccine programs.
METHODS
The intervention provided HPV vaccine at temporary school-located clinics to Guilford 
County middle school girls who sought immunization accompanied by one of their parents. 
School officials identified 6 regions in the county, and for each they selected a middle 
school to host 4 one-day clinics that provided HPV vaccine (ie, “host schools”). The 
county’s 16 other middle schools served as “satellite schools” whose students could receive 
HPV vaccine at the host school clinics in their region. Vaccine doses were free for the girls 
and their parents.
Planning
After securing grant funding for the intervention, the Guilford County Health Department 
made substantial initial efforts to create partnerships with key stakeholders to obtain access 
to the schools. Figure 1 shows the logic model guiding the development and implementation 
of this intervention, and below we provide more details about this process.
Local school system—The health department developed a collaborative partnership with 
the Guilford County School System. Seven months prior to the desired start of the school-
located vaccination clinics, they submitted a written proposal to the board of education 
describing HPV prevalence, risks, consequences of infection, and vaccination clinic 
execution plans. Once approved, the board members wrote guidelines for conducting the 
school-located vaccination clinics, described below. With assistance from the regional 
superintendent, they contacted the principals of the host schools to determine the dates of the 
clinics. The regional superintendent contacted the principals of the satellite schools to notify 
them that all of their female students would be eligible to attend the HPV vaccination clinics 
at the host schools.
Health department—The core intervention team consisted of a project manager, clerical 
support staff, and a health educator, all of whom were employees of the Guilford County 
Department of Public Health. The core team assigned school health nurses to staff the clinics 
and held in-service training sessions for the nurses. The core team also entered information 
on vaccines delivered in the clinics into the North Carolina Immunization Registry, a 
statewide electronic database that tracks the immunization status of children visiting public 
and private healthcare facilities.
The core team designed surveys assessing parents’ reasons for vaccinating their daughters, 
previous barriers to vaccination, and their overall assessment of the school-located 
vaccination clinics. Parents completed this survey during the post-vaccination observation 
period of the daughters’ third dose. For daughters who missed third doses, the team mailed 
their parents the surveys with prestamped return envelopes. By administering this survey at 
the end of the program, the study team was able to gather information on factors related to 
program completion, including reasons for participating and satisfaction with the program 
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activities. The consent packet contained a separate survey on a postcard without postage for 
parents who chose not to vaccinate their daughters at the school-located clinics to determine 
their reasons for not using the clinics.
In addition to handling vaccination clinic logistics, the core team devised the information 
and consent packet for girls to take home to their parents. The packets contained a cover 
letter approved and signed by the Guilford County health director and Guilford County 
Schools’ superintendent, the HPV and HPV vaccine fact sheet, the HPV vaccination consent 
form, the HPV vaccination waiver, clinic schedules, a statement that the vaccination clinics 
would incur no out-of-pocket expense, and an unstamped postcard survey (as described 
above) for parents declining vaccination. The packets were written at the eighth-grade 
reading level, and Spanish translations appeared on the back of all materials. The 
intervention plan was to send the packets home with every girl 2 weeks prior to the first 
vaccination clinics to allow enough time for the parents to read the packets and make a 
decision. Parents deciding to vaccinate their daughters at a school-located clinic brought 
signed consent forms from the packet to the first clinic; vaccinations provided during 
subsequent second and third dose clinics did not require additional consent.
The core team also provided education and outreach. As described above, education was 
promoted largely by the earlier campaign, “Don’t Wait… Educate!”17 In addition, during 
the vaccination intervention, a web campaign appeared on the Guilford County Department 
of Public Health website that provided continuing education and outreach to parents, and the 
health educator provided educational HPV presentations upon request. Parents also were 
reminded about the vaccination clinics through ConnectEd, an automated calling service, 
and the media relations manager promoted the school-located clinics through local media 
outlets.
Advisory team—To assist the core team, the project manager formed an advisory team of 
15 experts in various areas from the community, schools, and health department. All 
advisory team members worked part-time on the intervention and generally contributed one 
to 4 in-kind hours per week.
Implementation
The health department presented our proposal for school-located vaccination clinics to the 
county’s board of education in April 2009. The board approved our proposal by a 
contentious 6–5 vote with 5 major stipulations. First, the clinics had to take place during 
non-instructional hours. Second, parents had to be present for all of their daughters’ 
vaccinations, even if the parents signed a consent form. Third, the clinics could not put any 
additional burden or workload on school faculty and staff. Fourth, senior school staff had to 
approve materials sent home with students or mailed to parents. Fifth, senior school staff 
would determine how many and which schools would host the vaccination clinics.
Principals of the 6 designated host schools each agreed to offer a first dose clinic in October 
2009, a second dose clinic in December 2009, and a third dose clinic in April 2010, in line 
with dosing recommendations. 2 Most principals of the host schools (6/6, or 100%) and 
satellite schools (15/16, or 94%) agreed to distribute HPV vaccine information and consent 
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packets directly to the students. The information and consent packets took 2 months to 
create and receive approval from the local school system senior staff, local health director, 
and county attorney. Just prior to packet distribution, national media carried a negative story 
about the safety and potential side effects of the HPV vaccine. The officials who approved 
our packets asked our team to revise them to include a second, separate consent form that 
parents had to sign acknowledging the possibility of HPV vaccine side effects, including 
death. Due to concerns that the delayed packet distribution may have contributed to a low 
number of girls attending the first round of clinics offered in October, the team invited girls 
to receive their first dose of HPV vaccine at any of the clinics already planned in December 
2009, and they added 3 second-dose clinics in February 2010 and 3 third-dose clinics in 
June 2010.
Evaluation
The Institutional Review Board at the University of North Carolina determined that analysis 
of data from this study did not require their approval, because it was an evaluation of a 
quality improvement program. We gathered data on HPV vaccine doses delivered and 
schools’ demographic information. For the outcome evaluation, the primary outcome of 
interest was the number of middle school girls receiving at least one dose of HPV vaccine at 
a vaccination clinic at a host school, based on program records. Other outcomes were the 
number of middle school girls receiving all 3 doses and the total number of doses delivered, 
also from program records. We examined whether HPV vaccine initiation differed between 
designated host and satellite schools using mixed logistic regression models, treating school 
as a random effect because girls were clustered within schools. We examined differences in 
school size using the median score test. The analysis was 2-tailed, with a critical alpha of .
05, and conducted using SAS, version 9.2 (Cary, NC).
For the process evaluation, we characterized parents’ reasons for vaccination, barriers to 
prior vaccination, and evaluation of the school-located vaccination clinics among parents 
choosing to vaccinate their daughters. Postcard surveys of parents declining vaccination 
elicited their reasons for refusal. We documented the budgeted and actual expenses accrued, 
as well as in-kind expenses.
RESULTS
In total, the 6 host schools had 24 vaccination clinics between October 2009 and June 2010. 
Six middle schools hosted vaccination clinics, and 15 schools participated as satellite sites. 
Only one school that was eligible to be a satellite school declined to participate because the 
administration was concerned that parents would object. On average, satellite schools were 
10 miles away from their associated host school (range, 2–17 miles). Students from 7 
additional “ad-hoc” schools (6 high schools, one elementary school) attended school-located 
vaccination clinics at the host schools, and some students with unknown affiliations also 
attended the clinics. Staff provided these “ad-hoc” vaccinations as a courtesy to the parents.
The majority of host (67%), satellite (67%), and ad-hoc (57%) schools were city/urban 
schools (Table 1); the remaining schools were rural, except one that was suburban. The 
percentage of host and satellite schools with ≤ 40% economically disadvantaged students 
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was similar (33% vs. 27%), as was median seventh grade class size (both 24). In addition, 
host and satellite schools had similar percentages of students testing at or above their grade-
level on the Association of Boards of Certification (ABC) end-of-year tests for reading (67% 
and 69%) and math (84% and 82%). The median number of students attending the host 
(720), satellite (913), and ad-hoc schools (1160) did not differ (p = .14).
Outcome Evaluation
The median age of students served by the clinics was 12 years (range, 10–17 years), and the 
median grade in school was 7 (range, 4–12). The clinics provided HPV vaccine for 189 
girls: 171 attended a host or satellite school; 11 attended an ad-hoc school; and 7 did not 
indicate the schools they attended. A larger percentage of girls attending a host school 
received at least one dose of HPV vaccine compared to those that attended satellite middle 
schools (6% [110/1781] vs. 1% [61/6135], Figure 2). A logistic regression analysis 
confirmed this difference was statistically significant (OR = 6.56, 95% CI = 3.99–10.78).
The 171 girls attending host or satellite schools who received the HPV vaccine represent 
about 2% (171/7916) of the total population of their schools. Of girls who initiated the HPV 
vaccine series in the clinics, 80% (137/181) received all 3 doses of the series (Table 2).
Process Evaluation
Implementation—The intervention faced several implementation challenges. Two 
satellite schools did not distribute HPV vaccine information and consent packets to students 
as requested; instead, they sent a message informing parents to pick-up the packets from the 
school’s front office if they were interested in using the vaccination clinics. We estimate that 
parents of about 1000 (12%) girls in our target population of 7916 did not receive the 
material as a result. Difference in vaccine initiation between satellite and host schools 
remained statistically significant even after dropping these schools (p < .001).
The educational campaign included a Web presentation with voice narration that was 
removed from the Guilford County Department of Public Health website before the school-
located vaccination clinics ended because the space was needed for other information. An 
additional unanticipated communication barrier was not being allowed to use the school 
system television stations to promote the clinics. The intervention team conducted 27 
outreach presentations regarding HPV vaccine at the 21 host and satellite schools as part of 
this project (M = 1.3 presentations per school). They also conducted 18 outreach 
presentations to community groups, on request, including community organizations focusing 
on public health, medicine, and youth issues.
Parent surveys—Of 189 girls vaccinated, 63% (N = 119) of their parents completed post-
vaccination surveys. The most common reasons parents gave for getting their daughters 
HPV vaccine were that it was the best way to prevent HPV infection (86%) and because the 
potential health consequences of HPV infection could be serious (52%) (Table 3). The most 
common reasons parents gave for not vaccinating previously were high HPV vaccine cost 
and lack of knowledge of HPV (both 33%).
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All or almost all parents were pleased with their overall school-located clinic experiences 
(100%), wanted to see more partnering between the Guilford County School System and 
Guilford County Department of Public Health in the future (99%), and felt that the 
information provided by the intervention helped them to make informed decisions (97%–
99%) (Table 3).
Of parents who chose not to have their daughters receive HPV vaccine through our program, 
75 (~1%) returned a postcard survey. Most (77%) of these parents declined HPV vaccine at 
the school-located clinic because their daughters had already received HPV vaccine (Table 
3). Other reasons parents gave were that they questioned the safety and effectiveness of the 
vaccine (17%) or worried about potential side effects (13%).
Costs—The school-located clinics used only 36% of the $376,104 budget. The largest 
percentage of the expended budget went to personnel costs (67%); the Guilford County 
Department of Public Health contributed an additional 48 in-kind clinic staff hours and 534 
other in-kind staff hours. Whereas the second largest budget item was HPV vaccine itself 
(23%), vaccine expenses were lower than expected, which accounted for most of the budget 
surplus. The 2 main reasons for this difference between expected and actual costs were that 
the program delivered fewer vaccine doses than expected, and most doses were covered by 
either private insurance (46%) or the federal Vaccines for Children program (41%). Thus, 
the grant paid for doses of HPV vaccine for only 25 (13%) of the 189 participating girls.
DISCUSSION
We sought to create a model for partnership between a local school system and health 
department to provide administration of HPV vaccine. Although school-located HPV 
vaccine provision has been successful in other countries,5–9 the US has not examined it 
adequately as a way to increase vaccine coverage. Our extramural school-located HPV 
vaccination clinics provided HPV vaccine to 2% of girls attending middle school in Guilford 
County, North Carolina. Even accounting for the number of girls who had likely already 
initiated HPV vaccine prior to the campaign (around 50%, the rate of initiation of HPV 
vaccine among girls in 2009 in North Carolina19), which would reduce the number of 
eligible girls, vaccine initiation as part of the program was well short of our goal of 30%. 
The HPV vaccine initiation rate for the host schools of 6% was closer to the median 10% 
increase reported for other school-located HPV vaccine interventions in schools without 
health centers.13
More encouraging, completion of the 3-dose series was 80%, which was close to our goal of 
90%. The high completion rate suggests that school-located programs could be quite 
successful in the US if vaccine initiation were higher.
Lessons Learned
We offer several insights that may have improved HPV vaccination rates and could help 
future school-located vaccination clinics achieve their targets. Given that Guilford County 
schools did not have health centers, developing a stronger partnership between the local 
school system and the health department was a promising approach to increasing HPV 
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vaccination. However, it would have been beneficial to include leaders in the school system 
much earlier in the planning process, perhaps as early as the grant-writing phase of planning. 
Some school system leaders were resistant to efforts to provide HPV vaccine to middle 
school girls, which prevented the intervention team from communicating freely with satellite 
schools and from using certain communication resources, such as the school system 
television station. Involving school leaders in project development may have helped gain 
trust, understanding, and the support necessary to better promote HPV vaccine uptake at 
school-located vaccination clinics.
Focusing more generally on adolescent vaccines may elicit less resistance to HPV vaccine 
during planning of future interventions.13,20 The US Advisory Committee on Immunization 
Practices (ACIP) currently recommends administering tetanus booster and meningococcal 
vaccines during the same healthcare visit if both are indicated and available.21 HPV vaccine 
also can be given to adolescents at the same visit as other vaccines are provided, as doing so 
likely will increase the number of adolescents receiving vaccines on schedule.1 Because 
tetanus, diphtheria, and a cellular pertussis (Tdap) vaccine is required for entry into sixth 
grade in North Carolina and many other states,22 offering it in conjunction with other 
recommended vaccines during the transition from fifth to sixth grade would likely increase 
participation at clinics and vaccination rates for other recommended vaccines. Parents have 
expressed concerns about concomitant administration of vaccines,23–25 but most have 
allowed their children to receive multiple recommended vaccines during the same visit.26 In 
addition, programs in other countries that offer multiple adolescent vaccines concurrently 
have been successful in achieving high rates of uptake.7,8,27
Given that parents of younger students may participate more frequently in school events 
than parents of older students, it may be helpful to offer HPV education to parents of fifth-
grade students. As HPV vaccine is recommended for ages 11 or 12, and approved for ages 9 
through 26,1 most fifth graders (usually ages 10 to 11 years) would be eligible to receive 
HPV vaccinations at clinics held in their school. Finally, school-located clinics that occur 
during school hours (eg, lunchtime) may increase the ability to vaccinate children who 
might otherwise miss recommended but non-mandatory vaccines like HPV. For this 
intervention, the local school system required the presence of parents during all 
vaccinations, so the intervention team chose to offer them after school. The requirement that 
parents accompany their daughters may have contributed to low participation in our 
intervention.
Based on our results that revealed that the largest percentage of girls receiving vaccines at 
school-located clinics attended schools that hosted them, we recommend offering 
vaccination clinics in every school that contains the target population. As leaders from the 
local school system chose the number and schools that would host the vaccination clinics, 
we were unable to consider offering them at all 22 middle schools in the county. Given that 
the characteristics of host and satellite schools were similar, the lower participation rates for 
students at satellite schools may be due to the extra distance needed to travel to host schools, 
unfamiliarity with the host schools, and lack of visibility of the vaccination clinics.
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Publicizing school-located vaccination clinics is critically important. Although we believe 
the health department’s previous HPV education campaign generated support for the HPV 
vaccination clinics,17 marketing about specific clinic dates and times still had to go through 
the school system. School nurses and directors of health services were important mediators 
among parents, school system leaders, and the core team. We recommend that schools 
deliver communication messages using a variety of methods, such as in-person 
presentations, letters, health department and school system websites, television broadcasts, 
newspaper articles, radio messages, and email, as schools did during our intervention.
Obtaining parental consent for daughters to receive HPV vaccine was a significant 
challenge. Because of requirements from the school board, parents had to sign 2 consent 
forms and accompany daughters to all clinic visits. Opt-in consent processes are associated 
with reduced uptake of preventive services,28–30 and requiring parents to attend afterschool 
clinics only increased barriers to participation. Persons planning future interventions should 
consider opt-out consent processes or eliminating requirements for parents to accompany 
children, or taking steps to eliminate the need for parental consent.20 In Ontario,31 school-
located vaccination programs would waive the requirement for parental consent if program 
staff judged the student capable of providing consent, and in some US states, school health 
centers can provide preventive health services without notifying parents due to privacy 
laws.32 Other methods to increase the number of parents returning consent forms for school-
located vaccination programs include offering incentives and creating consent forms that are 
colorful and attractive.10
Finally, project budgets should include funds to mail vaccine information and consent 
packets to parents, put postage on surveys that parents need to return by mail, and pay 
school nurses for additional hours worked. We learned that some of the vaccine information 
and consent packets distributed to the principals to give to girls in their school never made it 
home to parents. We believe that had the intervention team prioritized funding for sending 
the packets directly to the parents, they would have been more likely to receive them, and 
more girls may have attended the clinics. In addition, few parents who did not get HPV 
vaccine for their daughters in the extramural clinics returned the postcard survey, but we 
believe that the response rate could have been much higher if the surveys had postage 
attached. Unfortunately, the intervention team was not able to include postage for the 
postcard surveys because the original budget did not account for this cost. However, they 
mailed reminders to the home of each girl that initiated vaccination at a school-located clinic 
that reminded parents when she was due for a subsequent dose, and we believe these 
personal reminders helped the intervention increase series completion.
Limitations and Strengths
Several of the lessons learned described above reflect limitations to this intervention. 
Although this team did attempt to generate buy-in from stakeholders early in the 
intervention development process, school principals were still hesitant to participate fully. 
The intervention team worked closely with school officials at the district level, but 
expanding this outreach to principals will be important for future school-located vaccine 
programs.
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In addition, the budget projections were different from the actual expenditures. The biggest 
discrepancy between projected and actual costs pertained to the cost of HPV vaccine doses 
provided by the program. Formative research to anticipate which portion of students would 
be able to receive HPV vaccine funded by federal programs or private insurance, instead of 
provided by the intervention, may have allowed us to allocate funds to increased advertising 
of the school-located clinics or postage for the surveys for non-participating parents. These 
efforts could have boosted participation in the program and the surveys, respectively, 
allowing us to have greater impact on HPV vaccination rates in this population as well as to 
draw stronger conclusions about why parents chose not to participate.
Another limitation was the low participation: 2% overall, with only 6% of girls at host 
schools receiving at least one dose of HPV vaccine. The reasons for this low rate of 
participation are unclear, but some possibilities include the barriers to participation (ie, 2 
consent forms, requiring parents to accompany daughters to after school clinics), poor 
communication with and advertising to parents, resistance to HPV vaccination, and the 
novelty of delivering a healthcare service in a school setting. We discuss some of these 
possibilities in more detail below.
With only one percent of non-participating parents returning their surveys, we cannot draw 
conclusions about why so many parents chose not to participate. We intended for these 
surveys to communicate information about why parents chose not to participate in HPV 
vaccine clinics; however, we cannot generalize from the parents who returned the postcards 
to the entire sample of parents in the host and satellite schools.
The study design also has some limitations. Though the study was not a randomized trial 
with assignment to condition, satellite schools served as a comparison for host schools; girls 
and parents attending satellite schools faced similar challenges to receiving the HPV vaccine 
as girls attending healthcare clinics, such as locating and travelling to the venue. The 
comparison of the 2 rests on the question of how the school superintendent assigned schools 
to condition, a factor that was beyond our control and may reflect other differences between 
the schools.
This intervention may have limited generalizability to other contexts. For instance, the 
majority of schools participating in this program were urban, so how the intervention would 
work in rural schools is less certain. In addition, this program took place during the 2009–
2010 school year, and in the time since then, the CDC has recommended that boys receive 
HPV vaccine as a routine part of preventive care.18 In addition, uptake of HPV vaccine has 
become more common, though coverage is still low.3 The intervention team did not use an 
“off-the-shelf” health behavior theory to guide the development of this program, though the 
intervention’s goals of increasing awareness and reducing barriers are consistent with a 
stage model of action. 33 Finally, this intervention involved a local health department 
partnering with a school, and partnerships with other types of organizations may have 
varying degrees of success. For instance, parents have low levels of trust towards drug 
companies, 34 so partnerships with such organizations may be less successful than 
partnerships with governmental or non-profit agencies.
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The study has several strengths. We evaluated the program under real-life conditions similar 
to those that many public health departments around the country face: limited time, 
uncertain budget, and challenges in working with stakeholders and the public. Although this 
study did not have the experimental control a randomized efficacy trial would, it represents a 
more replicable model of partnership between public health departments and schools to 
provide a time-limited intervention to boost vaccination. In addition, the program had high 
buy-in from schools, with 21 out of 22 eligible schools taking part in the program.
This program offered several innovations over previous vaccine interventions. Few school-
located HPV vaccine interventions have been conducted in the US.13 Compared to previous 
studies, this intervention was innovative in that it was the first to focus solely on HPV 
vaccine; it served a large number of students; and it built upon an educational campaign 
about HPV vaccine in the same county. This last innovation is especially important, given 
that parents commonly say that not knowing enough about HPV vaccine is a reason for not 
vaccinating their children.35–37 The program also focused on adolescents, whereas most 
previous school-located vaccination studies targeted younger children.10,38–41
The present study represents the first effort that we are aware of in the US to target a system 
of schools instead of intervening on single schools. Interventions in the United Kingdom and 
Australia, 5,7,8,42 which have exceptional rates of participation, operate under the auspices of 
national programs to boost HPV vaccination, which could suggest that political will and 
widespread, top-down dissemination could improve participation.
Conclusions
Whereas implementing school-located vaccination clinics delivered a modest number of 
HPV vaccine doses, we believe that such programs may improve HPV vaccination rates if 
intervention planning takes into account the aforementioned considerations. In particular, we 
believe that developing a partnership between local health departments and school systems 
when schools do not have pre-existing health centers is crucial to the success of school-
located vaccination clinics, and that this partnership should be well-established before 
clinics begin. Although other countries have demonstrated the effectiveness of school-
located vaccination clinics,5–9 our experiences provide important lessons for improving the 
effectiveness of future school-located vaccination clinics in the US. We hope that our report 
will assist others in developing and expanding school-located vaccination programs.
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Table 1
Characteristics of Participating Schools, Guilford County, 2009–2010
Host Schools Satellite Schools Ad-hoc Schools
Schools, N
 Overall 6 15 7
 Region
  City 4 10 4
  Suburbs 0 1 0
  Rural 2 4 3
 ≤40% students disadvantaged 2 4 3
 Met state standards for adequate yearly progress a 1 4 2
 Performance designation b
  Honor or excellent schools 2 4 1
  Progress schools 2 9 4
  Non-recognition or priority schools 2 2 2
Students, Median
 All grades (range) 720 (233–829) 913 (543–1104) 1160 (118–1386)
 Seventh grade (range) 24 (17–26) 24 (16–26) NA
 Tested at or above grade levelb
  Reading 67% 69% NA
  Math 84% 82% NA
 Acts of violence (per 100 students) 0 1 1
Teachers, Median
 ≥ 10 years of experience 38% 39% 46%
 Annual turnover 13% 11% 12%
Note.
a
Based on 29 goals that schools must meet under the No Child Left Behind Act.
b
Based on Association of Boards of Certification (ABCs) end-of-grade tests that are designed to measure student performance on the goals, 
objectives, and grade-level competencies specified in the North Carolina Standard Course of Study.
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Table 2
Doses of HPV Vaccine Provided to Middle School Girls at School-located Clinics (N=7916)
N (%)
No doses 7745 (97.9)
One dose 12 (0.2)
Two doses 22 (0.3)
Three doses 137 (1.7)
Note.
HPV vaccine series completion requires 3 doses
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Table 3
Parent Responses about Participating in School-located HPV Vaccines Clinics
%
Why did you decide to get your daughter HPV vaccine? (N = 119)
 It is the best way to prevent HPV infection. 86%
 The potential health consequences of HPV infection could be serious. 52%
 My daughter’s healthcare provider recommended it. 29%
 My daughter is, or will be, at risk of acquiring HPV. 24%
Why did you decide not to get your daughter HPV vaccine previously? (N = 119)
 HPV vaccine is too expensive. 33%
 I didn’t know enough about HPV. 33%
 It was inconvenient to make three appointments to receive all the shots. 29%
 I didn’t know enough about HPV vaccine. 28%
 HPV vaccine is not mandatory for school entry. 24%
Feedback about school-located HPV vaccine clinic. (N = 119)
 I was pleased with the overall experience. 100%
 I want to see more partnering between the Guilford County School System and the Guilford County Department of Public Health in 
the future.
99%
 I would recommend school-located vaccination clinics to friends and family. 100%
 I felt that the information and consent packet was sufficient to make an informed decision. 97%
 The other information I received from this project helped me to make an informed decision. 99%
Why did you choose not to have your daughter participate in our program? (N = 75)
 My daughter already received HPV vaccine. 77%
 I am not sure HPV vaccine is safe and effective. 17%
 I am worried about potential side effects of HPV vaccine. 13%
 I do not believe my daughter needs HPV vaccine. 9%
 I need more information before making a decision about HPV vaccine. 7%
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